Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease

scientific article

Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JNNP.56.8.859
P932PMC publication ID1015138
P698PubMed publication ID8350100
P5875ResearchGate publication ID14849402

P50authorMark B SchapiroQ114423687
James V. HaxbyQ23992770
Pietro PietriniQ25308513
Cheryl L. GradyQ26722137
Charles DeCarliQ28516591
P2093author name stringKumar A
Ball MJ
Kaye JA
P2860cites workCerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 yearsQ48746854
Pathological basis for neurotransmitter changes in Parkinson's diseaseQ48857336
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.Q52065251
Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.Q52120461
The morphological basis of dementia in Parkinson's disease.Q53198121
Integrated phylogeny of the primate brain, with special reference to humans and their diseasesQ57150906
TIME COURSE OF EFFECTS OF UNILATERAL LESIONS OF THE NUCLEUS BASALIS OF MEYNERT ON GLUCOSE UTILIZATION BY THE CEREBRAL CORTEXQ59858948
Local cerebral glucose utilization following unilateral and bilateral lesions of the nucleus basalis magnocellularis in the ratQ67948236
'Normal'-pressure hydrocephalus and the saga of the treatable dementiasQ69323561
Alternative formula for glucose utilization using labeled deoxyglucoseQ70349069
“Mini-mental state”Q25938989
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's DiseaseQ27860795
Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexQ29391304
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.Q34062645
Cerebral blood flow in dementiaQ34518886
Primary degenerative dementia without Alzheimer pathologyQ42526180
Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal featuresQ43458149
Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer typeQ44534844
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigraQ45020106
Severity of vascular dementia is related to volume of metabolically impaired tissueQ45238509
High-resolution PET studies in Alzheimer's diseaseQ45738975
Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer typeQ48292484
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementiaQ48305999
Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucoseQ48619036
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose methodQ48674190
Cortical cholinergic deficit in mentally impaired Parkinsonian patientsQ48736820
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
P304page(s)859-864
P577publication date1993-08-01
P1433published inJournal of Neurology, Neurosurgery and PsychiatryQ1599804
P1476titleReductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease
P478volume56

Reverse relations

cites work (P2860)
Q30784946A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile
Q37756103Autopsy as gold standard in FDG-PET studies in dementia.
Q41012601Diagnostic testing and dementia
Q35891782Neuroimaging and cognition in Parkinson's disease dementia.
Q27691820Neuroimaging biomarkers of neurodegenerative diseases and dementia
Q30756562Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology
Q40940214The clinical epidemiology of Alzheimer's disease
Q72136177The metabolic topography of parkinsonism

Search more.